Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Wilken

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Neuropharmacology|February 1, 1990
Stereochemical effects of 11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptorA C Howlett, T M Champion, G H Wilken, et al.
Neurotoxicology|July 22, 2009
Cytotoxicity of dopaminochrome in the mesencephalic cell line, MN9D, is dependent upon oxidative stressAndrew J Linsenbardt, Gerald H Wilken, Thomas C Westfall, et al.
Zentralblatt Fur Gynakologie|January 1, 1989
[Evaluation of the subrenal capsule assay (SRCA) in breast cancer using immunocompetent (NIC) mice]B Gerber, D Richter, E Rohde, et al.
Archiv Fur Geschwulstforschung|January 1, 1989
[Applicability of the subrenal capsule assay (SRCA) in primary breast carcinoma]B Gerber, D Richter, E Rohde, et al.
Biochemical Pharmacology|September 29, 2000
Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxyl ic acid phenylamide (CP-272871) for the CB(1) cannabinoid receptorJ P Meschler, D M Kraichely, G H Wilken, et al.
Neuroscience|February 9, 2018
The Neurotoxin DSP-4 Induces Hyperalgesia in Rats that is Accompanied by Spinal Oxidative Stress and Cytokine ProductionJillienne C Touchette, Joshua W Little, Gerald H Wilken, et al.
Journal of Neuroscience Methods|March 27, 2016
Simultaneous analysis of vascular norepinephrine and ATP release using an integrated microfluidic systemAlexandra D Townsend, Gerald H Wilken, Kyle K Mitchell, et al.
Molecular Pharmacology|April 4, 1998
Characterization of CB1 cannabinoid receptors using receptor peptide fragments and site-directed antibodiesA C Howlett, C Song, B A Berglund, et al.
Drug Design and Discovery|November 1, 1995
Structure-activity relationships defining the ACD-tricyclic cannabinoids: cannabinoid receptor binding and analgesic activityL S Melvin, G M Milne, M R Johnson, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|October 17, 1998
Structural requirements for arachidonylethanolamide interaction with CB1 and CB2 cannabinoid receptors: pharmacology of the carbonyl and ethanolamide groupsB A Berglund, D L Boring, G H Wilken, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Neuropharmacology|February 1, 1990
Stereochemical effects of 11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptorA C Howlett, T M Champion, G H Wilken, et al.
Neurotoxicology|July 22, 2009
Cytotoxicity of dopaminochrome in the mesencephalic cell line, MN9D, is dependent upon oxidative stressAndrew J Linsenbardt, Gerald H Wilken, Thomas C Westfall, et al.
Zentralblatt Fur Gynakologie|January 1, 1989
[Evaluation of the subrenal capsule assay (SRCA) in breast cancer using immunocompetent (NIC) mice]B Gerber, D Richter, E Rohde, et al.
Archiv Fur Geschwulstforschung|January 1, 1989
[Applicability of the subrenal capsule assay (SRCA) in primary breast carcinoma]B Gerber, D Richter, E Rohde, et al.
Biochemical Pharmacology|September 29, 2000
Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxyl ic acid phenylamide (CP-272871) for the CB(1) cannabinoid receptorJ P Meschler, D M Kraichely, G H Wilken, et al.
Neuroscience|February 9, 2018
The Neurotoxin DSP-4 Induces Hyperalgesia in Rats that is Accompanied by Spinal Oxidative Stress and Cytokine ProductionJillienne C Touchette, Joshua W Little, Gerald H Wilken, et al.
Journal of Neuroscience Methods|March 27, 2016
Simultaneous analysis of vascular norepinephrine and ATP release using an integrated microfluidic systemAlexandra D Townsend, Gerald H Wilken, Kyle K Mitchell, et al.
Molecular Pharmacology|April 4, 1998
Characterization of CB1 cannabinoid receptors using receptor peptide fragments and site-directed antibodiesA C Howlett, C Song, B A Berglund, et al.
Drug Design and Discovery|November 1, 1995
Structure-activity relationships defining the ACD-tricyclic cannabinoids: cannabinoid receptor binding and analgesic activityL S Melvin, G M Milne, M R Johnson, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|October 17, 1998
Structural requirements for arachidonylethanolamide interaction with CB1 and CB2 cannabinoid receptors: pharmacology of the carbonyl and ethanolamide groupsB A Berglund, D L Boring, G H Wilken, et al.
Pageof 7